Cas J Isfordink, Anders Boyd, Rachel Sacks-Davis, Daniela K van Santen, Colette Smit, Marianne Martinello, Mark Stoove, Juan Berenguer, Linda Wittkop, Marina B Klein, Andri Rauch, Dominique Salmon, Karine Lacombe, Ashleigh Stewart, Janke Schinkel, Joseph S Doyle, Margaret Hellard, Marc van der Valk, Gail V Matthews
BACKGROUND: Individuals with HIV and hepatitis C virus (HCV) who remain untreated with direct-acting antivirals can contribute to HCV transmission and HCV-related mortality. We aimed to compare rates of uptake of direct-acting antivirals following unrestricted access to this treatment in high-income countries and examine factors associated with remaining untreated. METHODS: This multinational, prospective cohort study used data from the International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)...
April 2023: Lancet. Public Health